Pankaj Gupta - Concepedia

Author

Pankaj Gupta

Also Known As

Dr. Pankaj Gupta, Gupta P, P Gupta, P. Gupta, PANKAJ GUPTA, Pankaj Gupta, Pankaj Kumar Gupta, Prof. Dr. Hemant Gupta, W Daum

116

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Central Council for Research in Homoeopathy Central Research Institute Probity Medical Research Kurukshetra University

About

Pankaj Gupta is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	1.3K
2	Engineering	1	1	40
3	Health Sciences	1	2	24
4	Management	1	1	40
5	Public Health	1	1	19

Pankaj Gupta

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial H. Bachelez, P.C.M. van de Kerkhof, Robert Strohal, The Lancet Autoimmune DiseaseClinical TrialsInflammatory MarkerClinical DermatologyTofacitinib Versus	2015	388
VEGF Prevents Apoptosis of Human Microvascular Endothelial Cells via Opposing Effects on MAPK/ERK and SAPK/JNK Signaling Kalpna Gupta, Smita Kshirsagar, Wei Li, Experimental Cell Research Vegf Prevents ApoptosisAngiogenesisOpposing EffectsAtherosclerosisMedicine	1999	380
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study Kim Papp, Alan Menter, Bruce Strober, British Journal of Dermatology	2012	328
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials Kim Papp, Alan Menter, Mai Abe, British Journal of Dermatology	2015	310
Efficacy and Safety of CE-224,535, an Antagonist of P2X<sub>7</sub>Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate Thomas Stock, Bradley J. Bloom, Nathan Wei, The Journal of Rheumatology	2012	232
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study Kim Papp, James G. Krueger, Steven R. Feldman, Journal of the American Academy of Dermatology	2016	151
Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis Kalpna Gupta, Pankaj Gupta, Robert Wild, Angiogenesis	1999	147
Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial Robert Bissonnette, Lars Iversen, Howard Sofen, British Journal of Dermatology	2014	144
Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression Sandra Frizelle, Jon Grim, Joan X Zhou, Oncogene MedicineTumor SuppressionMesothelioma Cells ResultsCell DeathPathology	1998	123
Herpes zoster in psoriasis patients treated with tofacitinib Kevin Winthrop, Mark Lebwohl, Arnon D. Cohen, Journal of the American Academy of Dermatology Herpes ZosterClinical DermatologyPharmacotherapyDermatologyMedicine	2017	65

Page 1